RT Journal Article
SR Electronic
T1 CX-072 (pacmilimab), a Probody PD-L1 inhibitor, in combination with ipilimumab in patients with advanced solid tumors (PROCLAIM-CX-072): a first-in-human, dose-finding study
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP e002446
DO 10.1136/jitc-2021-002446
VO 9
IS 7
A1 Sanborn, Rachel E
A1 Hamid, Omid
A1 de Vries, Elisabeth GE
A1 Ott, Patrick A
A1 Garcia-Corbacho, Javier
A1 Boni, Valentina
A1 Bendell, Johanna
A1 Autio, Karen A
A1 Cho, Daniel C
A1 Plummer, Ruth
A1 Stroh, Mark
A1 Lu, Lawrence
A1 Thistlethwaite, Fiona
YR 2021
UL http://jitc.bmj.com/content/9/7/e002446.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.